Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / GRCL - iSpecimen MultiPlan leads healthcare gainers; Gracell Biotechnologies Aurinia Pharmaceuticals among major losers

GRCL - iSpecimen MultiPlan leads healthcare gainers; Gracell Biotechnologies Aurinia Pharmaceuticals among major losers

Gracell Biotechnologies Inc.
Gainers: iSpecimen (NASDAQ:ISPC) +120%, MultiPlan (NYSE:MPLN) +21%, Provention Bio PRVB +20%, Stoke Therapeutics (NASDAQ:STOK) +16%, Star Equity STRR +14%. Losers: Gracell Biotechnologies (NASDAQ:GRCL) -31%, Aurinia Pharmaceuticals (NASDAQ:AUPH) -27%, Tivic Health Systems (NASDAQ:TIVC) -21%, Oramed Pharmaceuticals (NASDAQ:ORMP) -18%, Novo Integrated Sciences (NASDAQ:NVOS) -16%.

For further details see:

iSpecimen, MultiPlan leads healthcare gainers; Gracell Biotechnologies, Aurinia Pharmaceuticals among major losers
Stock Information
Company Name: Gracell Biotechnologies Inc.
Stock Symbol: GRCL
Market: NASDAQ
Website: gracellbio.com
Menu
GRCL GRCL Quote GRCL Short GRCL News GRCL Articles GRCL Message Board
Get GRCL Alerts

News, Short Squeeze, Breakout and More Instantly...